Scientists explore molecular links between stress, brain function, and personality disorders

A new scientific review published in Neuropharmacology explores how the environment interacts with brain biology in shaping personality disorders. By examining molecular, neurochemical, and metabolic pathways, the authors highlight promising directions for developing more personalized treatments. The review underscores how early life stress and environmental influences may lead to persistent changes in brain circuits responsible for emotion regulation and social behavior.

Personality disorders are a group of mental health conditions defined by long-lasting patterns of behavior, emotional response, and thinking that differ significantly from societal expectations. These patterns typically emerge in adolescence or early adulthood and can disrupt a person’s relationships, work, and self-image. The causes of personality disorders are complex, involving both inherited traits and life experiences. The authors of the review set out to explore how environmental exposures, such as childhood trauma and chronic stress, might alter the brain at a molecular level, increasing the risk for these disorders.

“The way the human brain adapts to the environment is of great interest in the neuroscience field, especially when exploring new avenues to treat mental health conditions that are currently poorly understood,” said the corresponding authors of the paper, Lorenzo More (a senior lecturer in neuroscience at the University of Central Lancashire), Ilaria Morella (assistant professor in pharmacology at Pavia University), and Andrew Shaw, (a lecturer in biomedical science at Glasgow University).

One of the central themes of the review is how environmental stress can shape the brain’s development through biological changes, a process known as environmental embodiment. The authors examine how specific molecular signaling pathways—namely Ras-ERK, p38, and mTOR—respond to external stimuli. These pathways regulate important brain functions like memory, stress responses, and social behavior. When disrupted, they may contribute to the kinds of emotional instability, impulsivity, and interpersonal difficulties seen in many personality disorders.

The review also discusses how certain chemicals in the brain, including serotonin, dopamine, noradrenaline, oxytocin, and vasopressin, are involved in the development and expression of personality disorder traits. For instance, reduced serotonin activity has been linked to increased impulsivity and emotional instability, while altered dopamine function may affect how people respond to rewards or frustration. Imbalances in oxytocin and vasopressin, which influence bonding and aggression, are believed to underlie some of the social and emotional challenges seen in people with disorders such as borderline or antisocial personality disorder.

Free daily newsletter

The authors draw particular attention to the brain’s energy systems, especially the role of mitochondria—tiny structures within cells that generate energy. These energy-producing systems are not just about keeping neurons running; they also help regulate the production of neurotransmitters like serotonin and dopamine. Studies in both humans and animal models have found that disruptions in mitochondrial function may be associated with traits like impulsivity and aggression. Additionally, the review highlights the role of oxidative stress—when harmful molecules called reactive oxygen species build up in the brain—in influencing how people react to stress and social situations.

Because personality disorders are difficult to model in animals, researchers have turned to studying smaller behavioral traits known as endophenotypes. These include behaviors such as heightened aggression or reduced social interaction. For example, one widely used test involves observing how mice respond to intruders, which gives insight into aggression levels. Although these models cannot capture the full complexity of human personality disorders, they help researchers identify biological mechanisms that might contribute to symptoms.

The review highlights “that antisocial traits — such as disproportionate aggression — which are characteristic of a clinical condition called antisocial personality disorder, result from imbalances in certain brain molecular pathways within cells,” the researchers told PsyPost. “These pathways can be influenced by one’s environment. For example, environments marked by high social competition increase the activity of p38, a ‘pro-stress’ molecular pathway, while reducing the activity of the Ras-ERK ‘anti-stress’ pathway.”

A key innovation discussed in the review is the potential development of “enviromimetic” drugs—medications that mimic the positive effects of healthy environmental experiences. These drugs would not treat symptoms in isolation, but instead activate the same molecular pathways that are engaged by nurturing social experiences or supportive environments. The goal is to reset or strengthen the biological systems involved in emotion regulation and social functioning.

“Targeting key components of the Ras-ERK pathway could enhance its cellular anti-stress effects and potentially reduce aggressive behaviors,” the researchers explained.

Some early examples of such interventions include ampakines—compounds that enhance the activity of specific brain receptors and may improve memory, plasticity, and sociability. Ampakines work by stimulating the Ras-ERK pathway, which is involved in learning and synaptic growth. Similarly, certain nutraceuticals, such as omega-3 fatty acids or saffron extract, may reduce inflammation and oxidative stress, which are increasingly recognized as contributors to emotional instability and aggression. These dietary supplements could complement existing therapies by supporting brain health at a cellular level.

The review also introduces a novel experimental compound called RB5, a cell-penetrating peptide that enhances ERK signaling in the brain. By mimicking certain deficiencies in ERK regulation, RB5 increases the activity of pathways involved in synaptic function and gene expression. This type of targeted molecular intervention might eventually help reduce aggressive or antisocial behaviors by recalibrating brain responses to social stimuli.

Looking ahead, the authors stress the need for more precise models of personality disorders that go beyond single traits like aggression. Many features of these disorders—such as a fragile sense of self, chronic feelings of emptiness, or fears of abandonment—are difficult to study in animals, leaving significant gaps in current knowledge. Future research may focus on combining genetic, molecular, and behavioral data to identify biomarkers that can guide personalized treatment strategies.

In particular, more work is needed “to better understand how the human brain encodes the valence of environmental stimuli, and how we can harness this knowledge to develop treatments for affective mental health conditions such as anxiety, depression, and schizophrenia,” the researchers said.

The review, “Neurobiology, molecular pathways, and environmental influences in antisocial traits and personality disorders,” was authored by Patryk M. Adamczyk, Andrew Shaw, Ilaria M. Morella, and Lorenzo More.